Fund Holdings — MPM BioImpact LLC

Total Portfolio Value:
$643.51M
Total Bought:
$188.26M
Total Sold:
$99.83M
Net Transaction:
+$88.42M
Notable People:
Ansbert K Gadicke
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)7,648,2687,648,2680$130.33M$133.39M20.73%+$3.06M
Insmed Incorporated(INSM)530,794615,391+84,597$14.40M$41.23M6.41%+$26.83M
Olema Pharmaceuticals, Inc.(OLMA)1,953,6902,654,867+701,177$22.12M$28.73M4.46%+$6.61M
iTeos Therapeutics, Inc.1,745,9431,745,9430$23.81M$25.91M4.03%+$2.10M
Crinetics Pharmaceuticals Inc.480,588557,184+76,596$22.50M$24.96M3.88%+$2.46M
Madrigal Pharmaceuticals, Inc.(MDGL)61,39971,185+9,786$16.40M$19.94M3.10%+$3.55M
Iovance Biotherapeutics, Inc.(IOVA)2,200,0002,366,714+166,714$32.60M$18.98M2.95%-$13.62M
Natera, Inc.(NTRA)172,413174,811+2,398$15.77M$18.93M2.94%+$3.16M
Mirum Pharmaceuticals, Inc.(MIRM)0492,569+492,569$0$16.84M2.62%+$16.84M
Ultragenyx Pharmaceutical Inc.(RARE)245,590380,552+134,962$11.47M$15.64M2.43%+$4.17M
MoonLake ImmunotherapeuticsCL A(MLTX)296,050343,235+47,185$14.87M$15.09M2.35%+$221.5K
Guardant Health, Inc.(GH)0500,000+500,000$0$14.44M2.24%+$14.44M
Disc Medicine, Inc.(IRON)110,779305,658+194,879$6.90M$13.78M2.14%+$6.88M
Alkermes plc(ALKS)0557,556+557,556$0$13.44M2.09%+$13.44M
Edgewise Therapeutics, Inc.(EWTX)441,259740,661+299,402$8.05M$13.34M2.07%+$5.29M
ALX Oncology Holdings Inc.(ALXO)1,268,4712,180,864+912,393$14.14M$13.15M2.04%-$992.8K
Morphic Holding Inc325,333369,384+44,051$11.45M$12.58M1.96%+$1.13M
Lantheus Holdings, Inc.(LNTH)0150,000+150,000$0$12.04M1.87%+$12.04M
Revolution Medicines, Inc.(RVMD)273,217289,396+16,179$8.81M$11.23M1.75%+$2.43M
Avadel Pharmaceuticals PLCADR871,149783,242-87,907$14.71M$11.01M1.71%-$3.70M
Xeris Biopharma Holdings Inc4,166,4964,830,526+664,030$9.21M$10.87M1.69%+$1.66M
Axsome Therapeutics, Inc.(AXSM)114,127132,312+18,185$9.11M$10.65M1.66%+$1.54M
Kalvista Pharmaceuticals Inc760,722881,937+121,215$9.02M$10.39M1.61%+$1.37M
Intellia Therapeutics, Inc.(NTLA)432,598443,503+10,905$11.90M$9.93M1.54%-$1.98M
Hillevax Inc0645,085+645,085$0$9.33M1.45%+$9.33M
Akero Therapeutics Inc332,924385,990+53,066$8.41M$9.06M1.41%+$645.7K
89Bio Inc967,7421,121,736+153,994$11.26M$8.99M1.40%-$2.28M
Fulcrum Therapeutics, Inc.(FULC)1,137,1081,444,851+307,743$10.73M$8.96M1.39%-$1.78M
Sutro Biopharma, Inc.(STRO)4,096,6193,043,346-1,053,273$23.15M$8.92M1.39%-$14.23M
Scholar Rock Holding Corporation(SRRK)01,028,330+1,028,330$0$8.57M1.33%+$8.57M
Relay Therapeutics, Inc.(RLAY)832,0171,274,459+442,442$6.91M$8.31M1.29%+$1.40M
Cartesian Therapeutics, Inc.(RNAC)0259,696+259,696$0$7.01M1.09%+$7.01M
REGENXBIO Inc.(RGNX)549,078557,076+7,998$11.57M$6.52M1.01%-$5.05M
Viking Therapeutics, Inc.(VKTX)150,000118,960-31,040$12.30M$6.31M0.98%-$5.99M
Zentalis Pharmaceuticals, Inc.(ZNTL)1,516,1831,450,000-66,183$23.90M$5.93M0.92%-$17.96M
Werewolf Therapeutics, Inc.(HOWL)2,388,0112,388,0110$15.47M$5.83M0.91%-$9.65M
Repare Therapeutics, Inc.1,639,8491,639,8490$7.72M$5.41M0.84%-$2.31M
Avidity Biosciences Inc0125,000+125,000$0$5.11M0.79%+$5.11M
Compass Therapeutics, Inc.(CMPX)1,971,4025,005,086+3,033,684$3.90M$5.01M0.78%+$1.10M
Adaptimmune Therapeutics plcADR(ADAPY)5,095,9125,095,9120$8.05M$4.97M0.77%-$3.08M
Immatics N.V.(IMTX)0417,810+417,810$0$4.85M0.75%+$4.85M
Trevi Therapeutics, Inc.(TRVI)1,340,9601,510,174+169,214$4.63M$4.50M0.70%-$126.0K
Verve Therapeutics, Inc638,163638,1630$8.47M$3.11M0.48%-$5.36M
Allakos0344,900+344,900$0$344.9K0.05%+$344.9K
Amicus Therapeutics Inc.
COM
718,9700-718,970$8.47M$0—-$8.47M
Geron Corporation(GERN)10,475,6750-10,475,675$34.57M$0—-$34.57M
Immatics NV395,2370-395,237$4.15M$0—-$4.15M
Viridian Therapeutics, Inc.(VRDN)614,0100-614,010$10.75M$0—-$10.75M
Page 1 of 1
MPM BioImpact LLC — 13F Holdings — Q2 2024 | TickerTrail